Alto Neuroscience Ownership | Who Owns Alto Neuroscience?
Alto Neuroscience Ownership Summary
Alto Neuroscience is owned by 92.90% institutional investors, 4.55% insiders, and 2.54% retail investors. Alpha wave global, lp is the largest institutional shareholder, holding 12.85% of ANRO shares.
ANRO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Alto Neuroscience | 92.90% | 4.55% | 2.54% |
| Sector | Healthcare Stocks | 35.38% | 11.35% | 53.27% |
| Industry | Biotech Stocks | 33.91% | 11.39% | 54.70% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Alpha wave global, lp | 3.71M | 12.85% | $83.35M |
| Commodore capital lp | 2.72M | 9.44% | $61.22M |
| Vestal point capital, lp | 2.06M | 7.15% | $46.40M |
| Perceptive advisors | 2.01M | 6.97% | $45.18M |
| Vanguard group | 1.37M | 5.04% | $24.31M |
| Franklin resources | 1.10M | 3.82% | $24.77M |
| Vivo capital | 1.04M | 3.59% | $23.28M |
| Armistice capital | 912.00K | 3.16% | $20.50M |
| Millennium management | 821.98K | 2.85% | $18.48M |
| 72 investment | 667.78K | 2.31% | $15.01M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| 72 investment | 667.78K | 30.26% | $15.01M |
| Alpha wave global, lp | 3.71M | 10.54% | $83.35M |
| Commodore capital lp | 2.72M | 3.54% | $61.22M |
| Vivo capital | 1.04M | 1.94% | $23.28M |
| Vestal point capital, lp | 2.06M | 1.30% | $46.40M |
| Ikarian capital | 515.00K | 0.94% | $11.58M |
| Perceptive advisors | 2.01M | 0.88% | $45.18M |
| Affinity asset advisors | 500.00K | 0.58% | $11.24M |
| Integral health asset management | 500.00K | 0.54% | $11.24M |
| Awm investment company | 170.00K | 0.42% | $3.82M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Commodore capital lp | 2.72M | 3.54% | 900.00K |
| Vr adviser | 500.00K | 0.42% | 500.00K |
| Affinity asset advisors | 500.00K | 0.58% | 500.00K |
| Jennison associates | 386.43K | 0.01% | 386.43K |
| Adage capital partners gp | 385.00K | 0.01% | 385.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 503.09K | 0.01% | -1.10M |
| Armistice capital | 912.00K | 0.36% | -624.00K |
| Vestal point capital, lp | 2.06M | 1.30% | -420.93K |
| Woodline partners lp | - | - | -359.87K |
| Peapod lane capital | - | - | -253.99K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vr adviser | 500.00K | 0.42% | 500.00K | $11.24M |
| Affinity asset advisors | 500.00K | 0.58% | 500.00K | $11.24M |
| Jennison associates | 386.43K | 0.01% | 386.43K | $8.69M |
| Adage capital partners gp | 385.00K | 0.01% | 385.00K | $8.65M |
| Vanguard fiduciary trust | 165.27K | 0.00% | 165.27K | $3.72M |
Sold Out
| Holder | Change |
|---|---|
| True wealth design | -126.00 |
| Sterling capital management | -161.00 |
| North star investment management | -174.00 |
| Nelson, van denburg & campbell wealth management group | -249.00 |
| Physician wealth advisors | -377.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 113 | 11.88% | 26,804,540 | 8.52% | 92 | 1.12% | 52 | -10.34% | 43 | 72.00% |
| Dec 31, 2025 | 18 | -76.62% | 1,951,777 | -88.35% | 7 | 0.19% | 10 | -60.00% | 4 | -85.19% |
| Sep 30, 2025 | 17 | -78.48% | 1,494,416 | -91.36% | 5 | 0.14% | 9 | -78.57% | 5 | -76.19% |
| Jun 30, 2025 | 79 | -7.06% | 17,296,404 | -16.08% | 63 | 1.10% | 42 | 7.69% | 21 | -16.00% |
| Mar 31, 2025 | 86 | 7.50% | 20,845,493 | -6.06% | 77 | 1.14% | 39 | -23.53% | 26 | 100.00% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 10, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | $38.75K |
| Jul 09, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | $18.25K |
| Jul 09, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | $133.83K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
ANRO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools